3, 7 or 3 and 7 thia or oxa prostanoic derivatives as agents for lowering intraocular pressure

Details for Australian Patent Application No. 2002259210 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert, M.; Holoboski, Mark; Posner, Mari, F.

Agent Davies Collison Cave

Pub. Number AU-B-2002259210

PCT Pub. Number WO2002/102389

Priority 10/103,301 20.03.02 US; 09/882,720 14.06.01 US

Filing date 13 May 2002

Wipo publication date 2 January 2003

Acceptance publication date 8 November 2007

International Classifications

C07D 333/56 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/5575 (2006.01)

A61K 31/559 (2006.01)

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07C 323/52 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

C07D 307/80 (2006.01) Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002259210

8 November 2007 Application Accepted

  Published as AU-B-2002259210

6 March 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002259211-METHODS AND REAGENTS FOR IDENTIFYING INSULIN RESPONSE MODULATORS AND THERAPEUTIC USES THEREFOR

2002259209-METHODS AND REAGENTS FOR IDENTIFYING INSULIN RESPONSE MODULATORS AND THERAPEUTIC USES THEREFOR